Oncology Room
In this room you can find updates and expert discussions in oncology.
SMC accepts venetoclax for untreated chronic lymphocytic leukaemia
Venetoclax is accepted for restricted use within NHS Scotland in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia.
Avapritinib not recommended for unresectable or metastatic gastrointestinal stromal tumours
Avapritinib not deemed cost-effective, according to NICE draft guidance.